Evidence map›Paper›PMID 35795982›Full record

ArticleBJPsych open2022

Post-traumatic stress in adults with 22q11.2 deletion syndrome.

Emma N M M von Scheibler, Thérèse A M J van Amelsvoort, Claudia Vingerhoets, Agnies M van Eeghen, Erik Boot

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Emma N M M von ScheiblerAdvisium, 's Heeren Loo Zorggroep, Amersfoort; and Department of Psychiatry and Neuropsychology, MHeNs, Maastricht University, The Netherlands.ORCID https://orcid.org/0000-0001-8698-946X
Thérèse A M J van AmelsvoortDepartment of Psychiatry and Neuropsychology, MHeNs, Maastricht University, The Netherlands.
Claudia VingerhoetsAdvisium, 's Heeren Loo Zorggroep, Amersfoort; and Department of Psychiatry and Neuropsychology, MHeNs, Maastricht University, The Netherlands.
Agnies M van EeghenAdvisium, 's Heeren Loo Zorggroep, Amersfoort; and Emma Children's Hospital, University of Amsterdam, The Netherlands.
Erik BootAdvisium, 's Heeren Loo Zorggroep, Amersfoort, The Netherlands; Department of Psychiatry and Neuropsychology, MHeNs, Maastricht University, The Netherlands; and The Dalglish Family 22q Clinic, University Health Network, Toronto, Canada.ORCID https://orcid.org/0000-0002-0593-1539
Maastricht University · NLEmma Kinderziekenhuis · NLUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

22q11.2 deletion syndrome (22q11.2DS) is associated with an elevated genetic risk of several psychiatric disorders. However, the prevalence of post-traumatic stress disorder (PTSD) in individuals with 22q11.2DS has been reported to be only 0.9%; this is lower than that of the general population (3.9%). We explored the occurrence of PTSD and traumatic events in a Dutch cohort of 112 adults with 22q11.2DS, and found PTSD in 8.0%, traumatic events in 20.5% and trauma-focused treatment in 17.9% of patients. Our novel findings suggest that PTSD may be underdiagnosed in individuals with 22q11.2DS. Clinicians and other caregivers should be alert to trauma in this population in order to enable treatment and minimise psychiatric burden.

Indexed as

22q11.2 deletion syndromeadultscognitive–behavioural therapyeye movement desensitisation reprocessingpost-traumatic stress disorder

Identifiers

PMID35795982
PMCPMC9301773
OpenAlexW4284668786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.